Tectonic Therapeutic - TECX Earnings per share for the trailing year

Official company branding of Tectonic Therapeutic Inc. (TECX)

Tectonic Therapeutic, Inc. (TECX) concentrates all its resources on developing a system of biologics to target GPCR receptors, which entails a high dependency on test results. This historical price chart reflects EPS dynamics, which currently stand at -20.00. The brand's high authority in protein therapy is evidenced by the effectiveness of the GEODE platform. Growth prospects are driven by interest from industry behemoths and the success of early-stage clinical trials.

Tectonic Therapeutic (TECX): Earnings per share for the last twelve months from 11/23/2025 to 11/18/2026

Tectonic - analytical breakdowns and key metrics (TECX)

- stock price and consensus target price:
- issuer market value details:
Fundamental company valuation:Tectonic Therapeutic, Inc.
Manufactured products of Tectonic Therapeutic Inc.

Year-over-year EPS growth (TTM) measures the dynamics of net income per share over a rolling year, reflecting the actual speed of business scaling. For Tectonic Therapeutic, Inc. (TECX), this metric is critical as the company transitions GPCR biologics into the clinical testing stage. By analyzing the current EPS YoY shift over the last 12 months, an investor can discern the pace of innovation capitalization. An acceleration in this metric may signal a revaluation of a low-liquidity asset.

Direct competitors

Earnings per share for the trailing year HLN (Haleon)|KVUE: Net earnings per share (EPS TTM)|Verona Pharma Corp - Earnings per share for the trailing year|MENS (Jyong Biotech Limited) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ligand.com LGND|Earnings per share for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALVO (Alvotech S.A.)|Liquidia Technologies - Earnings per share for the last twelve months|Galapagos Corp - Net earnings per share (EPS TTM)|ANIP (ANI Pharmaceuticals) - Earnings per share for the last 12 months|MannKind Corp. (MNKD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Net earnings per share (EPS TTM)|SPRY: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TBPH|Net earnings per share for the last four quarters Aquestive Therapeutics, Inc.|Earnings per share for the last twelve months scPharmaceuticals Inc. SCPH|Earnings per share for the trailing year TNXP|SXTC - Earnings per share for the last twelve months|Net earnings per share for the last four quarters eupraxiapharma.com EPRX|BHST: Net earnings per share (EPS TTM)|EXOZ - Net earnings per share for the last four quarters|ORMP (oramed.com) - Net earnings per share (EPS TTM)|enterabio.com (ENTX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HYFT|ABVC (ABVC BioPharma Inc) - Earnings per share for the trailing year|Cumberland Pharmaceuticals - Net earnings per share for the last 12 months|quantumbiopharma.com (QNTM) - Net earnings per one share for the last twelve months|FibroGen Inc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TELO (Telomir Pharmaceuticals Inc)|RANI (Rani Therapeutics Holdings, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Synergy CHC Corporation|Earnings per share for the last twelve months Rallybio Corp|Lexaria Bioscience (LEXX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pulmatrix, Inc. (PULM)|Net earnings per share for the last four quarters Pheton|Earnings per share for the last twelve months Aptorum Group Limited APM|LYRA - Net earnings per share for the last 12 months|IBO: Net earnings per share for the last 12 months|TNFA - Net earnings per share (EPS TTM)|cbdMD Corp (YCBD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months PRFX (PainReform Limited)|CYTO (Altamira Therapeutics Ltd.) - Net earnings per share (EPS TTM)|Lipella (LIPO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) OPTN|Net earnings per share (EPS TTM) pieris.com (PIRS)|Earnings per share for the last twelve months Procaps Group Corp PROC|Petros Pharmaceuticals Inc - Earnings per share for the last twelve months|Qilian International Corp - Net earnings per share (EPS TTM)|ACELYRIN, Inc. (SLRN) - Net earnings per share for the last 12 months|TFF Pharma (TFFP) - Earnings per share for the last twelve months